The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine

Abstract Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity are neglected in current influenza vaccines. To address this, a recombinant N1/N2 NA vaccine (NAV) was developed. Stability assays were used to determine optimal temperature and buffer conditions fo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luca T. Giurgea, Jae-Keun Park, Kathie-Anne Walters, Kelsey Scherler, Adriana Cervantes-Medina, Ashley Freeman, Luz Angela Rosas, John C. Kash, Jeffery K. Taubenberger, Matthew J. Memoli
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/e4321783a19a4370b86945991fe73acd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e4321783a19a4370b86945991fe73acd
record_format dspace
spelling oai:doaj.org-article:e4321783a19a4370b86945991fe73acd2021-12-02T14:17:31ZThe effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine10.1038/s41541-021-00310-x2059-0105https://doaj.org/article/e4321783a19a4370b86945991fe73acd2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00310-xhttps://doaj.org/toc/2059-0105Abstract Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity are neglected in current influenza vaccines. To address this, a recombinant N1/N2 NA vaccine (NAV) was developed. Stability assays were used to determine optimal temperature and buffer conditions for vaccine storage. The effect of divalent cation-related enhancement of NA stability and activity on N1 and N2 immunogenicity and efficacy against viral challenge was assessed. Differences in activity between N1 and N2 and cation-related activity enhancement did not translate into differences in immunogenicity or efficacy. NAV-vaccinated mice showed robust antibody titers against N1 and N2, and after challenge with influenza A (H1N1) virus, decreased viral titers and decreased antiviral and inflammatory responses by transcriptomic analysis. These findings provide guidance for optimal storage and assessment of NA-based vaccines and confirm the importance of NA in influenza vaccination strategies in attenuating viral replication and limiting inflammatory responses necessary to clear infection.Luca T. GiurgeaJae-Keun ParkKathie-Anne WaltersKelsey ScherlerAdriana Cervantes-MedinaAshley FreemanLuz Angela RosasJohn C. KashJeffery K. TaubenbergerMatthew J. MemoliNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Luca T. Giurgea
Jae-Keun Park
Kathie-Anne Walters
Kelsey Scherler
Adriana Cervantes-Medina
Ashley Freeman
Luz Angela Rosas
John C. Kash
Jeffery K. Taubenberger
Matthew J. Memoli
The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
description Abstract Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity are neglected in current influenza vaccines. To address this, a recombinant N1/N2 NA vaccine (NAV) was developed. Stability assays were used to determine optimal temperature and buffer conditions for vaccine storage. The effect of divalent cation-related enhancement of NA stability and activity on N1 and N2 immunogenicity and efficacy against viral challenge was assessed. Differences in activity between N1 and N2 and cation-related activity enhancement did not translate into differences in immunogenicity or efficacy. NAV-vaccinated mice showed robust antibody titers against N1 and N2, and after challenge with influenza A (H1N1) virus, decreased viral titers and decreased antiviral and inflammatory responses by transcriptomic analysis. These findings provide guidance for optimal storage and assessment of NA-based vaccines and confirm the importance of NA in influenza vaccination strategies in attenuating viral replication and limiting inflammatory responses necessary to clear infection.
format article
author Luca T. Giurgea
Jae-Keun Park
Kathie-Anne Walters
Kelsey Scherler
Adriana Cervantes-Medina
Ashley Freeman
Luz Angela Rosas
John C. Kash
Jeffery K. Taubenberger
Matthew J. Memoli
author_facet Luca T. Giurgea
Jae-Keun Park
Kathie-Anne Walters
Kelsey Scherler
Adriana Cervantes-Medina
Ashley Freeman
Luz Angela Rosas
John C. Kash
Jeffery K. Taubenberger
Matthew J. Memoli
author_sort Luca T. Giurgea
title The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
title_short The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
title_full The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
title_fullStr The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
title_full_unstemmed The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
title_sort effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant n1/n2 neuraminidase vaccine
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e4321783a19a4370b86945991fe73acd
work_keys_str_mv AT lucatgiurgea theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT jaekeunpark theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT kathieannewalters theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT kelseyscherler theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT adrianacervantesmedina theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT ashleyfreeman theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT luzangelarosas theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT johnckash theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT jefferyktaubenberger theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT matthewjmemoli theeffectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT lucatgiurgea effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT jaekeunpark effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT kathieannewalters effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT kelseyscherler effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT adrianacervantesmedina effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT ashleyfreeman effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT luzangelarosas effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT johnckash effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT jefferyktaubenberger effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
AT matthewjmemoli effectofcalciumandmagnesiumonactivityimmunogenicityandefficacyofarecombinantn1n2neuraminidasevaccine
_version_ 1718391639467098112